FMFukuko Moriya

Fukuko Moriya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fukuko Moriya has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correlation Between Work Motivation and Life Events in Female Physicians

    by Fukuko Moriya, Tatsuyuki Kakuma, Hitoshi Obara, Mihoko Mori, Megumi Hara, Miho Masuoka, Takuji Torimura, Mizuho Kido, Hirohisa Yano

    Summary: This study interviewed 39 mother-doctors from two university hospitals in Japan to investigate how certain stages in their lives influenced their working motivation. We conceptualized a Motivational Drive Chart to track changes of work motivation from enrollment in medical courses to the present day, recording changes in motivational values, age, and life events. It was found that the average value of motivation increased from the beginning of medical school enrollment until graduation; however, a sudden drop was noted in the age group 25 to 29 due to childcare and work-life conflicts. Motivational values were found to gradually increase in the 30 to 34 age group, owing to professional accomplishments, such as obtaining a specialist license. In Japanese society, social roles have traditionally been divided between men and women. The present study found that Japanese female doctors faced a decrease in work motivation during childrearing stages. The finding suggests that new avenues should be explored to support mother-doctors.


  • Open Access

    A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time

    by Masanori Noguchi, Fukuko Moriya, Shigetaka Suekane, Rei Ohnishi, Satoko Matsueda, Tetsuro Sasada, Akira Yamada, Kyogo Itoh

    Cancer vaccine is one of the attractive treatment modalities for patients with castration-resistant prostate cancer (CRPC). However, because of delayed immune responses, its clinical benefits, besides for overall survival (OS), are not well captured by the World Health Organization (WHO) and Response Evaluation Criteria in Solid Tumors (RECIST) criteria. Several surrogate markers for evaluation of cancer vaccine, including prostate-specific antigen doubling time (PSADT), are currently sought. The purpose of this study was to assess prospectively the PSA kinetics and immune responses, as well as the efficacy, safety, and biomarkers of personalized peptide vaccination (PPV) in progressive CRPC.


    • 1 September 2004
      • Vol. 50  (9) , 661-3

    [Paraurethral leiomyoma in women].

    by Fukuko Moriya, Nao Sakashita, Koujirou Saitoh, Shino Shimizu, Kei Matsuoka, Shogo Ueda

    We experienced a case of paraurethral leiomyoma in a 36-year-old woman. She had been complaining of dysuria. She had noticed the presence of a mass in anterior vagina. That mass was about 3 x 3 cm, floating moderately firm with a smooth face sited in a paraurethral region. Magnetic resonance imaging showed medium-signal intensity on T1-weighted images and a homogeneous low signal on T2-weighted images. We diagnosed it as a paraurethral leiomyoma and enucleated it by surgery. At histological examination the tumor resulted in being a leiomyoma. The diagnosis and the treatment of female paraurethral leiomyoma are discussed.